Patents by Inventor Gabriel Carpio

Gabriel Carpio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9399102
    Abstract: The present disclosure is directed to an injector device for delivering an ophthalmic solution to a cornea of an eye. The device may include a base configured to contact part of the eye, and a needle connected to the base, wherein needle may deliver the ophthalmic solution to the cornea.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: July 26, 2016
    Assignee: EUCLID SYSTEMS CORPORATION
    Inventors: Bruce H. Dewoolfson, Donald Harris, Mike Luttrell, Gabriel Carpio
  • Publication number: 20130144260
    Abstract: The present disclosure is directed to an injector device for delivering an ophthalmic solution to a cornea of an eye. The device may include a base configured to contact part of the eye, and a needle connected to the base, wherein needle may deliver the ophthalmic solution to the cornea.
    Type: Application
    Filed: June 24, 2011
    Publication date: June 6, 2013
    Inventors: Bruce H. Dewoolfson, Donald Harris, Mike Luttrell, Gabriel Carpio
  • Publication number: 20120057121
    Abstract: Methods of treating a refractive error of the eye are disclosed comprising applying a treatment that induces swelling of the corneal tissue and applying an orthokeratology lens configured to correct the refractive error that provides a controlled distribution of the corneal tissue.
    Type: Application
    Filed: February 23, 2010
    Publication date: March 8, 2012
    Inventors: Bruce H. Dewoolfson, Dale P. Devore, Braden Devore, George E. Glady, Gabriel Carpio, Donald H. Harris
  • Publication number: 20060034822
    Abstract: A thimerosal-free hyaluronidase preparation wherein the preferred hyaluronidase enzyme is devoid of molecular weight fractions below 40,000 MW, between 60-70,000 MW and above 100,000 MW. Also disclosed is a method for accelerating the clearance of hemorrhagic blood from the vitreous humor of the eye, said method comprising the step of contacting at least one hemorrhage-clearing enzyme (e.g., a ?-glucuronidase, matrix metalloproteinase, chondroitinase, chondroitin sulfatase or protein kinase) with the vitreous humor in an amount which is effective to cause accelerated clearance of blood therefrom.
    Type: Application
    Filed: August 15, 2005
    Publication date: February 16, 2006
    Inventors: Hampar Karageozian, Vicken Karageozian, Maria Kenney, Jose Gutierrez Flores, Gabriel Carpio Aragon, Anthony Nesburn
  • Publication number: 20050069531
    Abstract: An enzymatic method is provided for treating ophthalmic disorders of the mammalian eye. Prevention of neovascularization and the increased rate of clearance from the vitreous of materials toxic to retina is accomplished by administering an amount of hyaluronidase effective to liquefy the vitreous humor of the treated eye without causing toxic damage to the eye. Liquefaction of the vitreous humor increases the rate of liquid exchange from the vitreal chamber. This increase in exchange removes those materials and conditions whose presence causes ophthalmological and retinal damage.
    Type: Application
    Filed: November 12, 2004
    Publication date: March 31, 2005
    Inventors: Hampar Karageozian, Vicken Karageozian, Maria Kenney, Jose Flores, Gabriel Carpio Aragon, Anthony Nesburn